))
Market View: Eli Lilly, Novo Nordisk, JD.com, Johnson & Johnson, Lowe's, SATS, StarHub, and Gold
Manage episode 435322910 series 3000003
SPH Radio and MONEY FM 89.3에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 SPH Radio and MONEY FM 89.3 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Join Michelle Martin on her tour of markets! Today's discussion covers Eli Lilly's latest drug study results and competition with Novo Nordisk. Learn about JD.com's share price drop, Johnson & Johnson's acquisition, and Lowe's revised outlook. SATS’ return to profitability and StarHub's recent broadband outage are also on the agenda. Plus, discover insights into gold's record highs and China's growing nuclear power investments with Michelle and IG Markets Yeap Jun Rong.
See omnystudio.com/listener for privacy information.
챕터
1. Market View: Eli Lilly, Novo Nordisk, JD.com, Johnson & Johnson, Lowe's, SATS, StarHub, and Gold (00:00:00)
2. Marker 01 (00:00:11)
3134 에피소드
공유
